Clinical advances in viral-vectored influenza vaccines
Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...
Autors principals: | Sebastian, S, Lambe, T |
---|---|
Format: | Journal article |
Publicat: |
MDPI
2018
|
Ítems similars
-
Clinical Advances in Viral-Vectored Influenza Vaccines
per: Sarah Sebastian, et al.
Publicat: (2018-05-01) -
Viral vector vaccines
per: McCann, N, et al.
Publicat: (2022) -
Clinical development of viral vectored vaccines against MERS-COV
per: Ewer, K, et al.
Publicat: (2018) -
DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
per: D. A. Mezhenskaia, et al.
Publicat: (2018-12-01) -
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
per: Bissett, C, et al.
Publicat: (2024)